The expert from the Centre Hospitalier Lyon-Sud discussed the results of a phase II study of avelumab for patients with GTT who were resistant to chemotherapy.
Benoit You, MD, PhD
Advertisement
Articles by Benoit You, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Daraxonrasib Shows "Unprecedented" Survival in Pretreated Pancreatic Cancer
2
I-DXd Earns FDA Priority Review in Extensive-Stage Small Cell Lung Cancer
3
Impact of IGNYTE Trial Responses to RP1/Nivolumab in Advanced Melanoma
4
Navigating Proton Therapy, Immunotherapy Sequencing, and AI in HNC
5